Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi booster in toddlers previously primed with meningococcal conjugate vaccine
NCT05929651Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal A conjugate vaccine in invasive meningococcal disease (IMD), sponsored by Sanofi. Started Sep 2023; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT05929651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05929651.